Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Safety of migraine prophylaxis with calcitonin gene-related peptide monoclonal antibodies in comorbid chronic inflammatory central nervous system disease: A case series.

Headache·2026

Same author

Higher disease reactivation risk in women after fingolimod withdrawal.

Acta neuropathologica communications·2026

Same author

Listening to MS: AI-assisted speech analysis for diagnosis and fatigue prediction (COMMITMENT).

Frontiers in digital health·2026

Same author

Monitoring physical activity by fitness tracking devices : Usage, acceptance and willingness to share data in patients with multiple sclerosis.

Wiener klinische Wochenschrift·2026

Same author

The Clinical Implications of Sex on Waitlist Outcomes in Patients With Acute-on-Chronic Liver Failure.

Gastro hep advances·2026

Same author

A phase I, needle free, dose escalation clinical trial of pEVAC-PS, a candidate pan-Sarbecovirus Vaccine.

The Journal of infection·2026

Same journal

Fast Generation of F(Ab')<sub>2</sub> Fragments From Human IgG Using Fc-Fused IgG-Degrading Enzyme.

European journal of immunology·2026

Same journal

Generation of Regulatory T Cells Against Islet Neoantigen.

European journal of immunology·2026

Same journal

Complement Inhibition in the Clinic: Are We Doing Enough to Protect Patients From Infection?

European journal of immunology·2026

Same journal

Special Issue: yEFIS 3rd Symposium.

European journal of immunology·2026

Same journal

CRISPR/Cas9-Mediated Gene Knockout Reveals a Nonredundant Role for p16<sup>INK4A</sup> in Controlling TCR-Dependent and Independent CD8 T Cell Expansion.

European journal of immunology·2026

Same journal

Induction of Humoral and Cellular Immunity After SARS-CoV-2 JN.1 Vaccination in Individuals With and Without Prior Infection.

European journal of immunology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Sep 25, 2025

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

Multiple sclerosis: Immunopathological heterogeneity and its implications.

Britta Engelhardt¹, Manuel Comabella², Andrew Chan^3,4

¹Theodor Kocher Institute, University of Bern, Bern, Switzerland.

European Journal of Immunology

|April 27, 2022

Summary

This summary is machine-generated.

Multiple sclerosis (MS) is a complex autoimmune CNS disease. Understanding its heterogeneity is key to developing precise immunomodulatory therapies for better treatment outcomes.

Keywords:

precision medicine ⋅ biomarkers ⋅ brain barriers immunotherapy ⋅multiple sclerosis

More Related Videos

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Related Experiment Videos

Last Updated: Sep 25, 2025

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Area of Science:

Neuroimmunology
Clinical Neurology
Immunopathology

Background:

Multiple sclerosis (MS) is the most prevalent autoimmune demyelinating disease affecting the central nervous system (CNS).
Despite decades of research and development of immunomodulatory treatments, MS remains an incurable condition.
Existing therapies, while effective in early stages, do not fully address the disease's complexity.

Purpose of the Study:

To review the immune-pathophysiological and clinical heterogeneity observed in multiple sclerosis.
To explore how this heterogeneity impacts the development of targeted immunomodulatory treatment strategies.
To provide insights for more precise therapeutic approaches in MS management.

Main Methods:

Literature review focusing on immune-pathophysiology and clinical presentation in MS.
Analysis of studies investigating disease heterogeneity and its temporal variations.
Synthesis of current understanding of immune system and CNS plasticity in MS.

Main Results:

Significant heterogeneity exists in the clinical presentation of MS.
Immunophenotypes in MS patients display considerable variability and can change over time.
Functional plasticity within the immune system and the inflamed CNS contributes to disease complexity.

Conclusions:

The profound heterogeneity in MS pathophysiology and clinical manifestations presents a challenge for current treatments.
Recognizing and understanding this heterogeneity is crucial for advancing precision medicine in MS.
Future immunomodulatory strategies must account for individual patient variability for enhanced therapeutic efficacy.